기본 정보
연구 분야
프로젝트
논문
구성원
article|
gold
·인용수 2
·2023
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
Seung‐Jun Lee, Woong Chol Kang, Jong‐Young Lee, Jin‐Bae Lee, Tae‐Hyun Yang, Junghan Yoon, Yong‐Joon Lee, Sung‐Jin Hong, Chul‐Min Ahn, Jung‐Sun Kim, Byeong‐Keuk Kim, Young‐Guk Ko, Donghoon Choi, Bum‐Kee Hong, Yangsoo Jang, Myeong‐Ki Hong, Myeong‐Ki Hong, Donghoon Choi, Young‐Guk Ko, Byeong‐Keuk Kim, Jung‐Sun Kim, Chul‐Min Ahn, Sung‐Jin Hong, Seung‐Jun Lee, Yong‐Joon Lee, Bum‐Kee Hong, Hyuck Moon Kwon, Jong‐Youn Kim, Pil‐Ki Min, Young Won Yoon, Byoung Kwon Lee, Se‐Joong Rim, Eui‐Young Choi, Woong CholKang, Pyung Chun Oh, Jong‐Young Lee, Jin‐Bae Lee, Kee Sik Kim, Ji Yong Choi, Jae Kean Ryu, Seung Pyo Hong, Chang Yeon Kim, Tae‐Hyun Yang, Hyung-Jin Cho, Junghan Yoon, Chul‐Min Ahn, Sung Gyun Ahn, Seung‐Jun Lee, Jung‐Woo Son, Yangsoo Jang, Hyuck‐Jun Yoon, Cheol Hyun Lee, Jongmin Hwang, Yun‐Kyeong Cho, Seung‐Ho Hur, Seongwook Han, Chang‐Wook Nam, Hyoung Seop Kim, Hyoung‐Seob Park, In‐Cheol Kim, Yun‐Hyeong Cho, Hyeon‐Ju Jeong, Jin-Ho Kim, Chewan Lim, Yongsung Suh, Euiseok Hwang, Ji Hyun Lee, Sung Yun Lee, Sung Uk Kwon, Song‐Yi Kim, Keun Ho Park, Hyun Kuk Ki
IF 9.6EClinicalMedicine
초록

Sam Jin Pharmaceutical, Seoul, Korea and Chong Kun Dang Pharmaceutical, Seoul, Korea.

키워드
MedicineDiabetes mellitusStatinType 2 Diabetes MellitusInternal medicineIntensity (physics)Endocrinology
타입
article
IF / 인용수
9.6 / 2
게재 연도
2023

주식회사 디써클

대표 장재우,이윤구서울특별시 강남구 역삼로 169, 명우빌딩 2층 (TIPS타운 S2)대표 전화 0507-1312-6417이메일 info@rndcircle.io사업자등록번호 458-87-03380호스팅제공자 구글 클라우드 플랫폼(GCP)

© 2026 RnDcircle. All Rights Reserved.